Strict adherence to your doctor's dose-escalation schedule is essential
Adherence Analysis: Semaglutide QW Versus Other GLP-1 RAs As a result of the relatively short period of time from the launch of semaglutide QW to the index date, fewer patients receiving semaglutide QW were included in the adherence analysis at both 180 and 360 days ( n = 447 and n = 87, respectively), compared with patients receiving dulaglutide ( n = 17,073 and n = 7280, respectively) (Table 2), liraglutide ( n = 11,996 and n = 6137, respectively), and exenatide QW ( n = 5842 and n = 2683, respectively)
The cost structure is $25 per month for the treatment plan plus the separate cost of the medication itself
Our goal is to enhance your energy levels, improve mood, and support optimal metabolic function, helping you to feel your best every day